Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-116507
Filing Date
2025-11-28
Accepted
2025-11-26 17:48:35
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 tm2531771-1_s3.htm S-3 297001
2 EXHIBIT 5.1 tm2531771d2_ex5-1.htm EX-5.1 10773
3 EXHIBIT 23.2 tm2531771d2_ex23-2.htm EX-23.2 1718
4 EX-FILING FEES tm2531771d1_ex-filingfees.htm   iXBRL EX-FILING FEES 26014
5 GRAPHIC lg_altoneurosci-4clr.jpg GRAPHIC 18140
6 GRAPHIC tb_product-4c.jpg GRAPHIC 196280
7 GRAPHIC tm2531771d2_ex5-1img001.jpg GRAPHIC 2496
  Complete submission text file 0001104659-25-116507.txt   758905

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2531771d1_ex-filingfees_htm.xml XML 5392
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291834 | Film No.: 251531741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)